Governance Model For Scale: The Centerstone Case Study is starting in

For Addiction Treatment, Medication & Beyond

Use of medication for treating addiction on the increase. Over the past five years, we've seen the release of several new medications designed to address addiction (see FDA Approves New Opioid Addiction Treatment Combining Buprenorphine and Naloxone and FDA Approves Vivitrol for Opioid Dependence). And there are currently six new addiction treatment medications in late stage trials in the U.S. Food and Drug Administration (FDA) approval pipeline (see Predicting The Future Of Medications-More Options & More Medication Adherence).

The number of units paid by Medicaid for medication assisted treatment (MAT) for addiction disorder increased by 183% between . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!